AstraZeneca has announced $15 billion investment in China through 2030 to expand medicines manufacturing and R&D. Th...
Swiss firm SpiroChem AG and Japan-based Veritas In Silico Inc. have announced the signing of a Memorandum of Understandi...
China-based Simcere Pharmaceutical Group and Germany-headquartered Boehringer Ingelheim have announced a license and col...
Duke-NUS Medical School in Singapore has noted the announcement by Boehringer Ingelheim of a Phase IIa clinica...
US-based AbelZeta Pharma, Inc., a global clinical-stage biopharmaceutical company focused on the discovery and developme...
Dr. Peiqing Zhang, Scientific Director, Cytiva (Left) Dr. Timothy Tan, Associate Professor and Leading Investigator, NT...
To accelerate the co-development of Taiwan–U.S. startup ecosystems in artificial intelligence (AI), semiconductors...
AusBiotech welcomes the Australian Government's announcement, made by the Minister for Trade and Tourism, Senator the Do...
Australia-based AdAlta Limited, developer of next generation cell and protein therapeutic products, and its cellular imm...
China-based startup Zonsen PepLib Biotech Inc. has entered into a worldwide license agreement with Novartis for an undis...
Taiwan-based startup Leadgene Biosolutions has announced the expansion of its product portfolio following its strategic ...
US-based Curi Bio, the leader in delivering human-relevant functional data for drug discovery and development, has annou...
Taiwan based OBI Pharma has entered into a commercial license agreement with TegMine Therapeutics, Inc., a San Francisco...
China-based MediLink Therapeutics has entered into a new collaboration and exclusive licensing agreement with Roche for ...
US-based Revvity, Inc. has announced a collaboration with Eli Lilly and Company (Lilly) that expands acce...
Avance Clinical, a full-service Australia headquartered contract research organisation (CRO) focused on accelerating cli...
Ribo Life Science Co., a leading company in small interfering RNA (siRNA) therapeutics, has successfully listed on the M...
US-based startup Xellar Biosystems, a globally leading innovator in next-generation artificial intelligence (AI)- a...
Pandorum Technologies, a clinical-stage regenerative medicine company building a next-generation platform for programmab...
Hong Kong headquartered Insilico Medicine, a leading artificial intelligence (AI)-driven drug discovery company, has ann...
Insilico Medicine, a clinical-stage drug discovery and development company driven by generative artificial intelligence ...
Asia-Pacific’s life sciences landscape has always been shaped by contrasts. It is a region where scale and sophist...
The Japanese government has stepped up efforts to strengthen its startup ecosystem, rolling out a series of initiatives ...
The COVID-19 pandemic acted as both a challenge and a catalyst, serving as a testbed that fundamentally reshaped the bio...
mRNA first entered the global spotlight during COVID-19, turning companies such as Moderna and BioNTech into household n...
